Yahoo · Sep 1, 2026
Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing
Trump expanded his drug pricing deal to 26 pharma firms as UBS says healthcare stocks still have room to climb.
AL
OTC · ALPMY
Astellas Pharma Inc.
Healthcare · Drug Manufacturers - General
$14.22
Down-$0.20 (-1.41%)
Updated Sep 11, 2026, 11:40 AM
SID Score
6.5/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 29.58B
- P/E ratio
- 14.43
- Dividend yield
- 3.40%
- 52-week range
- — – —
- Volume
- 4K
- Avg. volume
- 127.41K
Price performance
ALPMY price history
1M range · 0 trading sessions · Daily adjusted prices
ALPMY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ALPMY news
The latest Smart Investors Daily articles mentioning ALPMY.
Stock researchCompany · Overview
ALPMY research
Overview
Company profile and research snapshot.
Company profile
ASTELLAS PHARMA UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Aug 31, 2026
Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has reached an agreement with the U.S. government that reflects our commitment to patient access, affordability and innovation, while reinforcing Astellas' longstanding commitment to the U.S. healthcare system.
Yahoo · Aug 31, 2026
Trump Announces Drug Pricing Deals with Teva, 8 Other Companies
The nine drug companies committed to collectively invest at least $19.6 billion in U.S. manufacturing in the near term.
Yahoo · Aug 31, 2026
Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms
The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
